137 related articles for article (PubMed ID: 26225544)
1. Polyphosphates form antigenic complexes with platelet factor 4 (PF4) and enhance PF4-binding to bacteria.
Brandt S; Krauel K; Jaax M; Renné T; Helm CA; Hammerschmidt S; Delcea M; Greinacher A
Thromb Haemost; 2015 Nov; 114(6):1189-98. PubMed ID: 26225544
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity.
Brandt S; Krauel K; Gottschalk KE; Renné T; Helm CA; Greinacher A; Block S
Thromb Haemost; 2014 Jul; 112(1):53-64. PubMed ID: 24671506
[TBL] [Abstract][Full Text] [Related]
3. Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia.
Krauel K; Pötschke C; Weber C; Kessler W; Fürll B; Ittermann T; Maier S; Hammerschmidt S; Bröker BM; Greinacher A
Blood; 2011 Jan; 117(4):1370-8. PubMed ID: 20959601
[TBL] [Abstract][Full Text] [Related]
4. Binding of anti-platelet factor 4/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4.
Kreimann M; Brandt S; Krauel K; Block S; Helm CA; Weitschies W; Greinacher A; Delcea M
Blood; 2014 Oct; 124(15):2442-9. PubMed ID: 25150299
[TBL] [Abstract][Full Text] [Related]
5. Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4/heparin-like epitopes.
Krauel K; Weber C; Brandt S; Zähringer U; Mamat U; Greinacher A; Hammerschmidt S
Blood; 2012 Oct; 120(16):3345-52. PubMed ID: 22942185
[TBL] [Abstract][Full Text] [Related]
6. Distinct Binding Characteristics of Pathogenic Anti-Platelet Factor-4/Polyanion Antibodies to Antigens Coated on Different Substrates: A Perspective on Clinical Application.
Nguyen TH; Greinacher A
ACS Nano; 2018 Dec; 12(12):12030-12041. PubMed ID: 30540167
[TBL] [Abstract][Full Text] [Related]
7. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
[TBL] [Abstract][Full Text] [Related]
8. Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4.
Jaax ME; Krauel K; Marschall T; Brandt S; Gansler J; Fürll B; Appel B; Fischer S; Block S; Helm CA; Müller S; Preissner KT; Greinacher A
Blood; 2013 Jul; 122(2):272-81. PubMed ID: 23673861
[TBL] [Abstract][Full Text] [Related]
9. Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity.
Nguyen TH; Medvedev N; Delcea M; Greinacher A
Nat Commun; 2017 May; 8():14945. PubMed ID: 28530237
[TBL] [Abstract][Full Text] [Related]
10. Biophysical tools to assess the interaction of PF4 with polyanions.
Delcea M; Greinacher A
Thromb Haemost; 2016 Oct; 116(5):783-791. PubMed ID: 27658429
[TBL] [Abstract][Full Text] [Related]
11. Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia.
Cines DB; Yarovoi SV; Zaitsev SV; Lebedeva T; Rauova L; Poncz M; Arepally GM; Khandelwal S; Stepanova V; Rux AH; Cuker A; Guo C; Ocariza LM; Travers RJ; Smith SA; Kim H; Morrissey JH; Conway EM
Blood Adv; 2016 Nov; 1(1):62-74. PubMed ID: 29296696
[TBL] [Abstract][Full Text] [Related]
12. Heparin enhances uptake of platelet factor 4/heparin complexes by monocytes and macrophages.
Joglekar M; Khandelwal S; Cines DB; Poncz M; Rauova L; Arepally GM
J Thromb Haemost; 2015 Aug; 13(8):1416-27. PubMed ID: 25960020
[TBL] [Abstract][Full Text] [Related]
13. New insights in heparin-induced thrombocytopenia by the use of fluid-phase assays to detect specifically platelet factor 4/heparin complex antibodies and antibody-secreting cells.
Schulze A; Jensch I; Krauel K; Alahmad A; Müller HP; Greinacher A; Hundt M
Thromb Res; 2014 Jul; 134(1):174-81. PubMed ID: 24816371
[TBL] [Abstract][Full Text] [Related]
14. Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA.
Palankar R; Kohler TP; Krauel K; Wesche J; Hammerschmidt S; Greinacher A
J Thromb Haemost; 2018 Jun; 16(6):1187-1197. PubMed ID: 29350833
[TBL] [Abstract][Full Text] [Related]
15. Reactivity of platelet-activating and nonplatelet-activating anti-PF4/heparin antibodies in enzyme immunosorbent assays under different conditions.
Nguyen TH; Wesche J; Raschke R; Strobel U; Bui VC; Delcea M; Greinacher A
J Thromb Haemost; 2019 Jul; 17(7):1113-1119. PubMed ID: 31009154
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
[TBL] [Abstract][Full Text] [Related]
18. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.
Greinacher A; Pötzsch B; Amiral J; Dummel V; Eichner A; Mueller-Eckhardt C
Thromb Haemost; 1994 Feb; 71(2):247-51. PubMed ID: 8191407
[TBL] [Abstract][Full Text] [Related]
19. Effect of pH and ionic strength on the binding strength of anti-PF4/polyanion antibodies.
Nguyen TH; Greinacher A
Eur Biophys J; 2017 Dec; 46(8):795-801. PubMed ID: 28712066
[TBL] [Abstract][Full Text] [Related]
20. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
